CJC1295 represents a growth hormone-releasing hormone (GHRH) analogue capable of stimulating growth hormone release. There are two variants of CJC1295: those with "DAC" (Drug Affinity Complex) and those "Without DAC".

Owing to its abbreviated half-life, CJC1295 without DAC can be expeditiously metabolized within the organism, potentially mitigating the propensity for adverse reactions